Mark Sale

1.4k total citations
42 papers, 1.1k citations indexed

About

Mark Sale is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Pharmacology. According to data from OpenAlex, Mark Sale has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 6 papers in Infectious Diseases and 6 papers in Pharmacology. Recurrent topics in Mark Sale's work include Cardiac electrophysiology and arrhythmias (6 papers), Statistical Methods in Clinical Trials (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Mark Sale is often cited by papers focused on Cardiac electrophysiology and arrhythmias (6 papers), Statistical Methods in Clinical Trials (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Mark Sale collaborates with scholars based in United States, Netherlands and United Kingdom. Mark Sale's co-authors include Chuanpu Hu, Raymond L. Woosley, Slawomir Wojtowicz‐Praga, Michael Hawkins, Elizabeth Ness, Michael D. Johnson, John B. Marshall, Rita A. Dickson, Robert R. Bies and Thomas A. Chiodo and has published in prestigious journals such as Journal of Clinical Oncology, Antimicrobial Agents and Chemotherapy and The American Journal of Cardiology.

In The Last Decade

Mark Sale

41 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Sale United States 18 257 226 216 142 140 42 1.1k
Rik de Greef United States 22 234 0.9× 721 3.2× 92 0.4× 109 0.8× 169 1.2× 65 1.7k
Alexander Staab Germany 23 445 1.7× 541 2.4× 79 0.4× 156 1.1× 376 2.7× 54 2.0k
QiPing Feng United States 22 424 1.6× 219 1.0× 145 0.7× 48 0.3× 183 1.3× 78 1.8k
Athanassios Iliadis France 23 468 1.8× 746 3.3× 166 0.8× 131 0.9× 149 1.1× 90 1.7k
MO Karlsson Sweden 17 203 0.8× 240 1.1× 41 0.2× 148 1.0× 56 0.4× 29 1.2k
Hao Zhu United States 18 315 1.2× 141 0.6× 47 0.2× 295 2.1× 129 0.9× 66 1.3k
Diane Potvin United States 20 274 1.1× 182 0.8× 71 0.3× 182 1.3× 76 0.5× 41 1.2k
Janet R. Wade United States 19 116 0.5× 191 0.8× 34 0.2× 193 1.4× 59 0.4× 37 1.0k
Ludger Banken Switzerland 19 345 1.3× 1.2k 5.1× 143 0.7× 34 0.2× 178 1.3× 40 2.3k

Countries citing papers authored by Mark Sale

Since Specialization
Citations

This map shows the geographic impact of Mark Sale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sale more than expected).

Fields of papers citing papers by Mark Sale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Sale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sale. The network helps show where Mark Sale may publish in the future.

Co-authorship network of co-authors of Mark Sale

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Sale. A scholar is included among the top collaborators of Mark Sale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Sale. Mark Sale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ismail, M., et al.. (2021). Development of a genetic algorithm and NONMEM workbench for automating and improving population pharmacokinetic/pharmacodynamic model selection. Journal of Pharmacokinetics and Pharmacodynamics. 49(2). 243–256. 20 indexed citations
3.
Xia, Pu, et al.. (2021). Population pharmacokinetics and exposure–response modeling for evinacumab in homozygous familial hypercholesterolemia. CPT Pharmacometrics & Systems Pharmacology. 10(11). 1412–1421. 8 indexed citations
4.
Mallayasamy, Surulivelrajan, Ayyappa Chaturvedula, Michael J. Fossler, et al.. (2019). Assessment of Demographic and Socio-Behavioral Factors on Adherence to HIV Pre-Exposure Prophylaxis Using a Markov Modeling Approach. Frontiers in Pharmacology. 10. 785–785. 6 indexed citations
5.
Struemper, Herbert, Mark Sale, Bela Patel, et al.. (2014). Population pharmacokinetics of ofatumumab in patients with chronic lymphocytic leukemia, follicular lymphoma, and rheumatoid arthritis. The Journal of Clinical Pharmacology. 54(7). 818–827. 22 indexed citations
6.
Sherer, Eric A., Mark Sale, Bruce G. Pollock, et al.. (2012). Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building. Journal of Pharmacokinetics and Pharmacodynamics. 39(4). 393–414. 21 indexed citations
7.
Mondick, John, Brendan M. Johnson, Mark Sale, et al.. (2009). Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1−48 months. European Journal of Clinical Pharmacology. 66(1). 77–86. 14 indexed citations
8.
Bies, Robert R., et al.. (2006). A Genetic Algorithm-Based, Hybrid Machine Learning Approach to Model Selection. Journal of Pharmacokinetics and Pharmacodynamics. 33(2). 195–221. 81 indexed citations
9.
Sale, Mark, Victor Biton, Alain Vuong, et al.. (2004). A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy. Epilepsy & Behavior. 6(1). 63–70. 6 indexed citations
10.
Hu, Chuanpu, Katy H. P. Moore, Yong H. Kim, & Mark Sale. (2004). Statistical Issues in a Modeling Approach to Assessing Bioequivalence or PK Similarity with Presence of Sparsely Sampled Subjects. Journal of Pharmacokinetics and Pharmacodynamics. 31(4). 321–339. 29 indexed citations
11.
Hu, Chuanpu & Mark Sale. (2003). A Joint Model for Nonlinear Longitudinal Data with Informative Dropout. Journal of Pharmacokinetics and Pharmacodynamics. 30(1). 83–103. 83 indexed citations
12.
Gidal, Barry E., et al.. (2003). Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy. Epilepsy Research. 57(2-3). 85–93. 64 indexed citations
13.
Moore, Katy H. P., Philip T. Leese, Scott McNeal, et al.. (2002). The pharmacokinetics of sumatriptan when administered with clarithromycin in healthy volunteers. Clinical Therapeutics. 24(4). 583–594. 15 indexed citations
14.
Moore, Katy H. P., et al.. (2002). The pharmacokinetics of sumatriptan when administered with norethindrone 1 mg/ethinyl estradiol 0.035 mg in healthy volunteers. Clinical Therapeutics. 24(11). 1887–1901. 7 indexed citations
15.
Barbey, Jean T., et al.. (1999). Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle-aged subjects. Clinical Pharmacology & Therapeutics. 66(1). 91–99. 22 indexed citations
16.
Wojtowicz‐Praga, Slawomir, Michael D. Johnson, John B. Marshall, et al.. (1998). Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.. Journal of Clinical Oncology. 16(6). 2150–2156. 196 indexed citations
17.
Flores‐Murrieta, Francisco Javier, Hui C. Ko, Francisco López‐Muñoz, et al.. (1998). Pharmacokinetic–Pharmacodynamic Modeling of Tolmetin Antinociceptive Effect in the Rat Using an Indirect Response Model: A Population Approach. Journal of Pharmacokinetics and Biopharmaceutics. 26(5). 547–557. 20 indexed citations
18.
Verdino, Ralph J., Cynthia M. Tracy, Allen J. Solomon, Mark Sale, & Jean T. Barbey. (1997). Alterations in Heart Rate Following Radiofrequency Ablation in the Treatment of Reentrant Supraventricular Arrhythmias: Relation to Alterations in Autonomic Tone. Journal of Interventional Cardiac Electrophysiology. 1(2). 145–151. 3 indexed citations
19.
Sale, Mark, Jean T. Barbey, Raymond L. Woosley, et al.. (1994). The electrocardiographic effects of cetirizine in normal subjects. Clinical Pharmacology & Therapeutics. 56(3). 295–301. 54 indexed citations
20.
Woosley, Raymond L. & Mark Sale. (1993). QT interval: A measure of drug action. The American Journal of Cardiology. 72(6). B36–B43. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rik de Greef Breakdown of academic impact, for papers by Alexander Staab Breakdown of academic impact, for papers by QiPing Feng Breakdown of academic impact, for papers by Athanassios Iliadis Breakdown of academic impact, for papers by MO Karlsson Breakdown of academic impact, for papers by Hao Zhu Breakdown of academic impact, for papers by Diane Potvin Breakdown of academic impact, for papers by Janet R. Wade Breakdown of academic impact, for papers by Ludger Banken
Rankless by CCL
2026